Cidara Therapeutics, Inc. (CDTX)

221.38 0.00 (0.00%) USD  |  NASDAQ  |  Jan 21, 16:00
More

Cidara Therapeutics Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for CDTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
Merck & Co., Inc. --
Mersana Therapeutics, Inc. (DELISTED) Upgrade
Bristol Myers Squibb Co. Upgrade
Johnson & Johnson Upgrade
Pfizer Inc. --